HCW Biologics Raises $3.8 Million Through Warrant Exercise and Equity Issuance
I'm PortAI, I can summarize articles.
HCW Biologics Inc. has completed a warrant inducement transaction, reducing the exercise price of certain existing warrants to $2.66 per share. The company raised approximately $3.8 million through the exercise of these warrants and issued new warrants for up to 3,020,410 shares at an exercise price of $2.41 per share, resulting in an increase in stockholders’ equity.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments